Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.

Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.

Vitamin D exerts immunomodulatory effects on the host response against infection with hepatitis C virus (HCV). This study was performed to assess the putative influence of polymorphisms in vitamin D-related genes on the response to antiviral therapy in patients with chronic hepatitis C (CHC).Single...

Full description

Bibliographic Details
Main Authors:	Elena García-Martín, José A G Agúndez, María L Maestro, Avelina Suárez, Marta Vidaurreta, Carmen Martínez, Cristina Fernández-Pérez, Luis Ortega, José M Ladero
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3779247?pdf=render

Similar Items

Association of Single Nucleotide Polymorphisms in the VDR and CYP27B1 Genes with Risk of Developing Vitamin D3 Deficiency
by: Hormoz Selahvarzi, et al.
Published: (2021-03-01)

Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease.
by: José A Agúndez, et al.
Published: (2012-01-01)

Placental mRNA and Protein Expression of VDR, CYP27B1 and CYP2R1 Genes Related to Vitamin D Metabolism in Preeclamptic Women
by: Justyna Magiełda-Stola, et al.
Published: (2021-12-01)

Effect of Vitamin-D-Enriched Edible Mushrooms on Vitamin D Status, Bone Health and Expression of CYP2R1, CYP27B1 and VDR Gene in Wistar Rats
by: Muneeb Ahmad Malik, et al.
Published: (2022-08-01)

Combination therapy for chronic hepatitis C: interferon and ribavirin.
by: Christie, J, et al.
Published: (1999)

Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C
by: T Bischof, et al.
Published: (2007-07-01)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01)

Vitamin D, Vitamin D-Binding Proteins, and VDR Polymorphisms in Individuals with Hyperglycaemia
by: Rajiv Erasmus, et al.
Published: (2022-07-01)

Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms
by: Francesco La Marra, et al.
Published: (2017-06-01)

Standard Interferon and Ribavirin Response in Patients with Chronic Hepatitis C
by: Muhammad Murtaza Bukhari
Published: (2013-12-01)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
by: Roberto J Carvalho-Filho, et al.
Published: (2010-03-01)

Comparison study between the treatment of Hepatitis C virus with (peg-interferon, ribavirin, silymarin) and (peg-interferon, ribavirin) in Baghdad teaching hospital.
by: Khalid A. Al-Khazraji
Published: (2017-04-01)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
by: Saleem Sana, et al.
Published: (2011-05-01)

Association Between VDR and CYP24A1 Polymorphisms, Atopic Dermatitis, and Biochemical Lipid and Vitamin D Profiles in Spanish Population: Case-Control Study
by: Ricardo González-Tarancón, et al.
Published: (2023-06-01)

Response of Hepatitis C Patients to Alpha Interferon and Ribavirin Combination Therapy
by: Ihsanullah Mahsud, et al.
Published: (2004-06-01)

Pegylated Interferon (Alone or With Ribavirin) for Chronic Hepatitis C in Haemodialysis Population
by: Mario Espinosa, et al.
Published: (2015-05-01)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions Vitamin D pathways unbalanced in breast lesions
by: Lopes Nair, et al.
Published: (2010-09-01)

Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.
by: José Manuel Cuevas, et al.
Published: (2008-08-01)

Vitamin D Status, VDR, and TLR Polymorphisms and Pulmonary Tuberculosis Epidemiology in Kazakhstan
by: Dauren Yerezhepov, et al.
Published: (2024-02-01)

Vitamin D and VDR Gene Polymorphisms’ Association with Rheumatoid Arthritis in Lithuanian Population
by: Egle Punceviciene, et al.
Published: (2021-04-01)

Vitamin D Receptor (VDR) Gene BsmI Polymorphisms in Lupus Nephritis
by: Mahnaz Abbasi, et al.
Published: (2011-02-01)

The Relationship of FokI Polymorphism in Vitamin D Receptor (VDR) Gene and Obesity
by: Maryam Ostadsharif, et al.
Published: (2015-11-01)

Association between vitamin D, <i>VDR</i> polymorphism and IVF outcomes
by: Anastasiia G. Syrkasheva, et al.
Published: (2022-01-01)

Impact of Vitamin D Receptor VDR rs2228570 Polymorphism in Oldest Old
by: Melanie Glocke, et al.
Published: (2013-09-01)

Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection: A rare complication
by: Felipe Sahidt Ortega-Ibarra, et al.
Published: (2013-06-01)

TREATMENTS OF HEPATITIS C VIRUS LIVER CIRRHOSIS WITH PEGYLAT INTERFERON-RIBAVIRIN AND INTERFERON FREE – COMPARATIVE STUDY
by: S.A. Florescu, et al.
Published: (2016-12-01)

Association of SNPs In Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
by: Zohreh Heidari, et al.
Published: (2014-10-01)

Genetic variants of VDR and CYP2R1 affect BMI independently of serum vitamin D concentrations
by: Bence Bakos, et al.
Published: (2020-06-01)

Combination therapy with interferon-alpha and ribavirin for hepatitis C: practical treatment issues.
by: Collier, J, et al.
Published: (2001)

Retinal Changes In Patients with Hepatitis C Virus under treatment with interferon and ribavirin.
by: Mansour Hassan, et al.
Published: (2020-01-01)

Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C
by: Chi-Hsuan Chiang, et al.
Published: (2014-12-01)

Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin
by: Debora Lucia Seguro Danilovic, et al.
Published: (2011-01-01)

Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
by: Aline Gonzalez Vigani, et al.

The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin
by: Hamid Kalantari, et al.
Published: (2019-01-01)

Effect of IL-28 B Polymorphisms on Early Virological Response (EVR) in Chronic Hepatitis C Patients Treated with Interferon and Ribavirin
by: Madeeha Nazar
Published: (2016-09-01)

Vitamin D receptor (VDR) gene polymorphism and osteoporosis risk in White British men
by: Melissa Kow, et al.
Published: (2019-07-01)

Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.
by: Yanling Liu, et al.
Published: (2013-01-01)

Vitamin D Receptor (VDR) Polymorphisms and Late-Onset Alzheimer's Disease: An Association Study.
by: Hamid Reza Khorram Khorshid, et al.
Published: (2013-11-01)

Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk
by: José M Ladero, et al.
Published: (2012-12-01)